ScholarIQanswers from OpenAlex & ORCID
Vladimir Makarov
ResearcherPublications, citations & collaboration network
Vladimir Makarov is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Vladimir Makarov have?
ScholarIQindexed works
Vladimir Makarov has 44 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Vladimir Makarov have?
ScholarIQcitation count
Vladimir Makarov has 27,527 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Vladimir Makarov?
ScholarIQh-index
Vladimir Makarov has an h-index of 29 in OpenAlex.
What is the i10-index of Vladimir Makarov?
ScholarIQi10-index
Vladimir Makarov has an i10-index of 31 in OpenAlex.
What is the ORCID of Vladimir Makarov?
ScholarIQorcid
The ORCID for Vladimir Makarov is on the source record.
What is the OpenAlex record for Vladimir Makarov?
ScholarIQopenalex
The OpenAlex for Vladimir Makarov is on the source record.
What are the most-cited papers on Vladimir Makarov?
ScholarIQmost cited works
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Naiyer A. Rizvi, Matthew D. Hellmann, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J. Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa Ho, Martin L. Miller, Natasha Rekhtman, André L. Moreira, Fawzia K. Ibrahim, Cameron Bruggeman, Billel Gasmi, Roberta Zappasodi, Yuka Maeda, Chris Sander, Edward B. Garon, Taha Merghoub, Jedd D. Wolchok, Ton N. Schumacher, Timothy A. Chan
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan, Andrew J.S. Furness, Rachel Rosenthal, Sofie Ramskov, Rikke Lyngaa, Sunil Kumar Saini, Mariam Jamal‐Hanjani, Gareth A. Wilson, Nicolai J. Birkbak, Crispin T. Hiley, Thomas B.K. Watkins, Seema Shafi, Nirupa Murugaesu, Richard Mitter, Ayse U. Akarca, Joseph Linares, Teresa Marafioti, Jake Y. Henry, Eliezer M. Van Allen, Diana Miao, Bastian Schilling, Dirk Schadendorf, Levi A. Garraway, Vladimir Makarov, Naiyer A. Rizvi, Alexandra Snyder, Matthew D. Hellmann, Taha Merghoub, Jedd D. Wolchok, Sachet A. Shukla, Catherine J. Wu, Karl S. Peggs, Timothy A. Chan, Sine Reker Hadrup, Sergio A. Quezada, Charles Swanton
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Diego Chowell, Luc G.T. Morris, Claud Grigg, Jeffrey K. Weber, Robert Samstein, Vladimir Makarov, Fengshen Kuo, Sviatoslav M. Kendall, David Requena, Nadeem Riaz, Benjamin D. Greenbaum, James M. Carroll, Edward B. Garon, David M. Hyman, Ahmet Zehir, David B. Solit, Michael F. Berger, Ruhong Zhou, Naiyer A. Rizvi, Timothy A. Chan
Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy
Robert Samstein, Chirag Krishna, Xiaoxiao Ma, Xin Pei, Ken-Wing Lee, Vladimir Makarov, Fengshen Kuo, Jonathan Chung, Raghvendra M. Srivastava, Tanaya A. Purohit, Douglas R. Hoen, Rajarsi Mandal, Jeremy Setton, Wei Wu, Rachna Shah, Besnik Qeriqi, Qing Chang, Sviatoslav M. Kendall, Lior Z. Braunstein, Britta Weigelt, Pedro Blecua, Luc G.T. Morris, Diana Mandelker, Jorge S. Reis‐Filho, Elisa de Stanchina, Simon N. Powell, Timothy A. Chan, Nadeem Riaz
Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma
Allen S. Ho, Angelica Ochoa, Gowtham Jayakumaran, Ahmet Zehir, Cristina Valero Mayor, Justin Tepe, Vladimir Makarov, Martin G. Dalin, Jie He, Mark Bailey, Meagan Montesion, Jeffrey S. Ross, Vincent A. Miller, Lindsay Chan, Ian Ganly, Snjezana Doğan, Nora Katabi, Petros Tsipouras, Patrick K. Ha, Nishant Agrawal, David B. Solit, P. Andrew Futreal, Adel K. El Naggar, Jorge S. Reis‐Filho, Britta Weigelt, Alan L. Ho, Nikolaus Schultz, Timothy A. Chan, Luc G.T. Morris